CompanyHealthHardware
Kytopen
Kytopen is a Cambridge, Massachusetts biotech and MIT spinout building Flowfect, a non-viral, continuous-flow platform that uses fluid flow plus electric fields to deliver mRNA, DNA and CRISPR payloads into cells. The technology aims to engineer hundreds of billions of cells in minutes, removing a major bottleneck in discovering, developing and manufacturing advanced cell therapies like CAR-T and NK-cell treatments.
2017Founded
CambridgeHQ
UndisclosedSeries B
cell-therapytransfectionnon-viral-gene-deliveryflowfectelectroporation-alternativebiomanufacturing